FDA,geographicatrophy,Vision,ophthalmology

Mashup Score: 4

FDA fast tracks one-time intravitreal gene therapy for geographic atrophy - 20 hour(s) ago

The FDA granted fast track designation to SAR446597, an intravitreal gene therapy for the treatment of geographic atrophy due to age-related macular degeneration, according to a press release from Sanofi.

Source: www.healio.com

Categories: General Medicine News, Ophthalmology

Tweet Tweets with this article
- Healio_OSN
  
  ❗BREAKING❗ A one-time intravitreal gene therapy has received fast track designation from the #FDA for the treatment of #geographicatrophy. Find out more: https://t.co/TGukXHYHJE #Vision #ophthalmology @sanofi https://t.co/lssYYBSh4z